Thomas Ryder Applied Nutrition

Applied Nutrition CEO Thomas Ryder

Applied Nutrition is aiming to become a household name as its once-specialised range of sports nutrition products gain greater mainstream visibility throughout the major supermarkets and GLP-1 use continues to grow in the UK.

CEO Thomas Ryder told The Grocer today, after the group reported a year of strong growth, that the company had barely scratched the surface of its full potential.

“UK grocery is definitely a huge play for us,” he said. “It will help us become a household brand. We want to appeal to the husband, the wife and the kids. And to do that we need to be in multiple aisles in the supermarkets.”

Applied Nutrition has expanded outside of partnerships with health retailers such as Holland & Barrett, which went “from strength to strength” for the brand last year, to secure a presence in the mainstream grocery retailers, which Ryder called a “significant milestone”.

“Supermarkets are increasingly becoming destinations for sports nutrition,” he added. “That’s evident with our pre-workouts. We launched around six to nine months ago and I thought it was too early. I didn’t think the grocers were ready for those types of specialist products. Our head of retail convinced me otherwise, and he was absolutely right. The data shows the rate of sale is great and it is performing really well. Consumers are going to supermarkets for specialist sports nutrition products that they may previously have bought elsewhere.”

The group is now in all the big four supermarkets following a recent launch with Sainsbury’s.

“We are getting deeper distribution with our existing products, such as creatine, diet protein, hydration tablets and energy gels, which are all selling really well. And we believe we have a lot more growth to come from the grocers in terms of adding more products and deeper distribution with existing lines,” Ryder said.

Revenues at the London-listed group in the year ended 31 July 2026 increased 51% to £161.6m and adjusted EBITDA rose 40% to £43.3m. Applied Nutrition twice upgraded its profit expectations during the year on the back of the popularity of product launches, new retail partnerships and expansion in international markets such as North America.

“Very strong momentum” continued into the first quarter of the new financial year, but the board maintained current market expectations for FY27 of £205m in sales (up 27%) and £49m EBITDA (up 13.5%).

Growing demand for the sports nutrition, health and wellness market around the world is creating tailwinds for Applied Nutrition, with more female consumers buying hydration, collagen and creatine than ever before.

And the rapid uptake of weight-loss drugs is also contributing to growth at the business thanks to specialist GLP-1 ranges and the launch of high-protein food products with Morrisons as part of the group’s first out-licensing agreement.

“We used the GLP-1 range to attract and support consumers using weight-loss medications,” Ryder said. “Hopefully, as that consumer continues on their health journey, they should just become an Applied Nutrition customer, migrating from the GLP-1 products to our core range.

“It’s a massive cohort of consumers using GLP-1 and with the introduction of the oral version you are going to see many more taking this medication. We want to appeal to these consumers because we believe these are the fundamental ingredients and formulas they need while using this medication.”

Ryder also expects to strike ne licensing deals in the new financial year.

“The range with Morrisons has been really successful for us. The biggest benefit has been visibility in aisles we would not have been in before and being seen by consumers we might have never been in front of previously. We are getting a lot more incoming enquiries from other companies to license Applied Nutrition to put on the front of their products.”